Results 121 to 130 of about 4,939,655 (307)

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

High speed all optical networks [PDF]

open access: yes
An inherent problem of conventional point-to-point wide area network (WAN) architectures is that they cannot translate optical transmission bandwidth into comparable user available throughput due to the limiting electronic processing speed of the ...
Chlamtac, Imrich, Ganz, Aura
core   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Hot Tensile Behavior of 05Cr17Ni4Cu4Nb Stainless Steel: Damage Model and Fracture Characteristics

open access: yesMetals
This study investigates the hot tensile behavior and fracture characteristics of 05Cr17Ni4Cu4Nb stainless steel through isothermal tensile tests conducted under various deformation parameters.
Jing Yuan   +3 more
doaj   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Investigation of Asymmetric Flow of a Slender Body with Low-Aspect Ratio Fins Having Large Deflection Angles

open access: yesAerospace
To understand the asymmetric flow of a slender body with low-aspect ratio fins, a wind tunnel experiment was carried out, and the asymmetric flow was observed when the pair of fins had a symmetric deflection angle of 30° at a small angle of attack and ...
Yonghong Li   +4 more
doaj   +1 more source

Dynamic balancing of high-speed rotary machinery [PDF]

open access: yes, 1970
Rotary dynamics test facility investigates and corrects imbalances in rotary components at speeds up to 60,000 rpm.
Bodensieck, E. J., Pronasko, S.
core   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Key technologies for future combat of intelligent variant aircraft

open access: yesHangkong gongcheng jinzhan
Intelligent variant aircraft is one of the important development directions of advanced aircraft in the future, and it is also an innovative research frontier in the aerospace field.
CAO Xin   +5 more
doaj   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy